Acute coronary syndromes: Rivaroxaban reduces serious CV events without increasing fatal bleeding in patients with a recent ACS
- PMID: 22124321
- DOI: 10.1038/nrcardio.2011.181
Acute coronary syndromes: Rivaroxaban reduces serious CV events without increasing fatal bleeding in patients with a recent ACS
Comment on
-
Rivaroxaban in patients with a recent acute coronary syndrome.N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13. N Engl J Med. 2012. PMID: 22077192 Clinical Trial.
References
-
- N Engl J Med. 2012 Jan 5;366(1):9-19 - PubMed
Publication types
LinkOut - more resources
Full Text Sources